METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.

[1]  M. Wei,et al.  The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. , 2022, Cancer cell.

[2]  Wei Liu,et al.  METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis , 2022, Nature Cell Biology.

[3]  J. Eirín-López,et al.  Evolution of Methyltransferase-Like (METTL) Proteins in Metazoa: A Complex Gene Family Involved in Epitranscriptomic Regulation and Other Epigenetic Processes , 2021, Molecular biology and evolution.

[4]  N. Chandel,et al.  Cancer metabolism: looking forward , 2021, Nature Reviews Cancer.

[5]  Chuan He,et al.  A Critical Role of Nuclear m6A Reader YTHDC1 in Leukemogenesis by Regulating MCM Complex-Mediated DNA Replication. , 2021, Blood.

[6]  Jianjun Chen,et al.  RNA modifications in hematopoietic malignancies: A new research frontier. , 2021, Blood.

[7]  D. Patel,et al.  N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. , 2021, Cancer cell.

[8]  Andrew J. Bannister,et al.  Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia , 2021, Nature.

[9]  Amanda E. Jones,et al.  Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia , 2021, Nature Genetics.

[10]  Lei Jiang,et al.  R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis. , 2021, Molecular cell.

[11]  Yue Huang,et al.  Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. , 2020, Cancer cell.

[12]  Chuan He,et al.  RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia. , 2020, Cell stem cell.

[13]  Shaoguang Li,et al.  Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis. , 2020, Cell stem cell.

[14]  S. Yamashita,et al.  Mechanistic insights into m6A modification of U6 snRNA by human METTL16 , 2020, Nucleic acids research.

[15]  Jianjun Chen,et al.  RNA Modifications in Cancer: Functions, Mechanisms, and Therapeutic Implications , 2020, Annual Review of Cancer Biology.

[16]  Jianjun Chen,et al.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. , 2020, Cancer cell.

[17]  Ji Ae Song,et al.  Glucose-dependent control of leucine metabolism by leucyl-tRNA synthetase 1 , 2019, Science.

[18]  Michael G. Kharas,et al.  m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment , 2019, Cell reports.

[19]  D. O’Carroll,et al.  Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia , 2019, Cell stem cell.

[20]  T. Pulinilkunnil,et al.  Role of branched‐chain amino acid–catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Lei Ding,et al.  Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation , 2019, Nature Cell Biology.

[22]  C. Winter,et al.  A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma , 2019, Scientific Reports.

[23]  R. Deberardinis,et al.  Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation. , 2019, Cancer discovery.

[24]  Ping-yuan Wang,et al.  Structural Basis for Regulation of METTL16, an S-Adenosylmethionine Homeostasis Factor. , 2018, Molecular cell.

[25]  A. McCarthy,et al.  Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development , 2018, Molecular cell.

[26]  Wengong Wang,et al.  Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration , 2018, Cell Research.

[27]  Xi C. He,et al.  Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion , 2018, Cell Research.

[28]  Wen-jie Dong,et al.  Mettl3–Mettl14 methyltransferase complex regulates the quiescence of adult hematopoietic stem cells , 2018, Cell Research.

[29]  Jianjun Chen,et al.  RNA N6-methyladenosine modification in cancers: current status and perspectives , 2018, Cell Research.

[30]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[31]  James E. Bradner,et al.  R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling , 2018, Cell.

[32]  Yue Sheng,et al.  METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. , 2017, Cell stem cell.

[33]  Tsutomu Suzuki,et al.  S-Adenosylmethionine Synthesis Is Regulated by Selective N6-Adenosine Methylation and mRNA Degradation Involving METTL16 and YTHDC1. , 2017, Cell reports.

[34]  Junwei Shi,et al.  Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control , 2017, Nature.

[35]  S. Fröhling,et al.  BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation , 2017, Nature.

[36]  Henning Urlaub,et al.  Human METTL16 is a N6‐methyladenosine (m6A) methyltransferase that targets pre‐mRNAs and various non‐coding RNAs , 2017, EMBO reports.

[37]  F. Liu,et al.  m6A modulates haematopoietic stem and progenitor cell specification , 2017, Nature.

[38]  Francine E. Garrett-Bakelman,et al.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal and leukemia cells , 2017, Nature Medicine.

[39]  Phillip G. Montgomery,et al.  Defining a Cancer Dependency Map , 2017, Cell.

[40]  Yang Xie,et al.  The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention , 2017, Cell.

[41]  N. Kannan,et al.  Cancer progression by reprogrammed BCAA metabolism in myeloid leukemia , 2017, Nature.

[42]  D. Pollyea,et al.  Therapeutic targeting of acute myeloid leukemia stem cells. , 2017, Blood.

[43]  Jie Jin,et al.  FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. , 2017, Cancer cell.

[44]  J. Steitz,et al.  Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA , 2016, Proceedings of the National Academy of Sciences.

[45]  Jiwang Zhang,et al.  miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia , 2016, Nature Communications.

[46]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[47]  R. Deberardinis,et al.  Metabolic pathways promoting cancer cell survival and growth , 2015, Nature Cell Biology.

[48]  Daniel J Weisdorf,et al.  Acute Myeloid Leukemia. , 2015, The New England journal of medicine.

[49]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[50]  G E Tomlinson,et al.  WTAP is a novel oncogenic protein in acute myeloid leukemia , 2014, Leukemia.

[51]  Hunter N. B. Moseley,et al.  A Computational Framework for High-Throughput Isotopic Natural Abundance Correction of Omics-Level Ultra-High Resolution FT-MS Datasets , 2013, Metabolites.

[52]  Rainer König,et al.  BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1 , 2013, Nature Medicine.

[53]  Y. Saunthararajah,et al.  AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. , 2013, Blood.

[54]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[55]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[56]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[57]  S. Clarke,et al.  Uncovering the Human Methyltransferasome* , 2010, Molecular & Cellular Proteomics.

[58]  J. Rowley,et al.  Leukaemogenesis: more than mutant genes , 2010, Nature Reviews Cancer.

[59]  Hunter N. B. Moseley,et al.  Correcting for the effects of natural abundance in stable isotope resolved metabolomics experiments involving ultra-high resolution mass spectrometry , 2010, BMC Bioinformatics.

[60]  P. Yaswen,et al.  A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells , 2009, PloS one.

[61]  S. Armstrong,et al.  Therapeutic Implications of Leukemia Stem Cell Development , 2007, Clinical Cancer Research.

[62]  M. Cleary,et al.  Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. , 2006, Cancer cell.

[63]  T. Golub,et al.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.

[64]  Ming Yan,et al.  A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis , 2006, Nature Medicine.

[65]  M. Brosnan,et al.  Branched-chain amino acids: enzyme and substrate regulation. , 2006, The Journal of nutrition.

[66]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Dick,et al.  Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity , 2004, Nature Immunology.

[68]  William C Hahn,et al.  Lentivirus-delivered stable gene silencing by RNAi in primary cells. , 2003, RNA.

[69]  R. Naviaux,et al.  The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses , 1996, Journal of virology.

[70]  R. Miller,et al.  Branched-chain amino acid metabolism. , 1984, Annual review of nutrition.